Good morning from OWITH.ai: the podcast that gives you only what's important to hear in the AI and tech world. Oura, a company renowned for its smart rings and valued at $11 billion, has decided to delay its much-anticipated IPO, initially planned for late September 2026. CEO Tom Hale cited "uncertainty in the IPO market" as the reason for this decision. The plan was to sell 50 million shares priced between $40 and $44 each, potentially raising $2.1 billion in gross proceeds. However, concerns arose over Oura's valuation, which might have reached $15.6 billion, being high for a company primarily reliant on its core product—a smart ring. The main issue was whether investors view Oura as merely a hardware manufacturer or as a broader AI-enabled digital health platform with expansion potential. Additionally, the IPO's financial structure raised concerns, as only 27% of the shares were to be newly issued by Oura, with 73% sold by existing shareholders. This could have resulted in $567 million in gross proceeds for Oura and approximately $1.53 billion for selling shareholders, suggesting to investors that the IPO might focus more on liquidity for existing investors rather than growth for the company. Competition from tech giants like Apple further complicates Oura's market position. Despite these challenges, there is still a possibility that Oura could attempt another IPO in the future, though no specific timeline has been provided. In other financial news, several companies have secured significant funding rounds. Vinci raised $250 million for its AI-powered simulation software; Type One Energy secured $200 million for its stellarator fusion technology; and General Medicine raised $120 million to enhance its healthcare marketplace. Additional notable fundraises include Stuut with $52.5 million, Vitalize with $31 million, and Furientis with $25 million in seed funding. The private equity landscape also saw activity with Advantage Investigations acquiring Norstar Investigations and Marlin Equity Partners acquiring a minority stake in Rystad Energy. Oceansound Partners acquired a majority stake in Imsar, while Thermal Technology Distribution Solutions acquired Thermal Products. The integration of AI into military operations is a growing concern discussed by Sarah Yager, OpenAI's first Human Rights and Responsible Deployment Lead, during the ScaleUp:AI conference in New York City. Yager expressed anxiety over the military's use of AI in autonomous weapons and targeting systems, emphasizing the ethical and human rights implications. Her role at OpenAI involves addressing challenges posed by AI's military applications. OpenAI's collaboration with the U.S. military, formalized in a contract signed in February 2026, underscores the importance of Yager's position. This partnership followed a disagreement between the Pentagon and OpenAI's competitor, Anthropic, over ethical considerations. Since joining OpenAI in June 2026, Yager has influenced AI model development to ensure compliance with international agreements like the Geneva Conventions. Despite efforts to align AI with established human rights standards, real-world applications remain problematic. An incident involving an AI-generated intelligence report nearly led to a misdirected U.S. military strike on a Chinese vessel, raising concerns about AI reliability in critical military decisions. Yager argues against AI companies independently defining morality and humanity, advocating for established human rights as foundational. Bayer's CEO, Bill Anderson, has significantly restructured the company by reducing managers from 16,000 to 4,500 within a workforce of 88,000. This managerial flattening is part of a broader transformation aimed at making Bayer more agile and efficient. Instead of traditional hierarchies and annual budgets, Bayer now operates with 5,000 small teams working on 90-day cycles. Anderson emphasizes empowering employees and decentralizing decision-making. He believes leaders should set visions rather than dictate goals, with 95% of decision-making occurring at lower organizational levels. This shift aims to foster "courageous authenticity and decisiveness," addressing what Anderson sees as a softer company culture. Financially, Bayer's stock has increased by 57% over the past year but lags over three years compared to peers like BASF and Novartis. Anderson has improved profitability and achieved a significant Supreme Court ruling related to liability claims; however, sustaining revenue and profit growth remains crucial. The Fortune AIQ Summit held at the New York Stock Exchange emphasized that AI success in large companies relies more on people management than technology itself. The summit highlighted insights on how Fortune 500 companies effectively implement AI at scale. A key takeaway was that "pacesetter" companies invest heavily in upskilling employees—57% engaging in AI training compared to only 4% of others. Speakers like futurist Amy Webb stressed adaptability over technical expertise when leveraging AI; suggesting flexibility and learning ability are crucial skills organizations must foster. The summit also discussed tensions between effective deployment versus governance concerns around AI risks. In conclusion, these narratives underline rapid advancements across various sectors while highlighting challenges inherent within transformative technologies such as artificial intelligence amidst fluctuating market conditions globally!Support the show Thanks for listening! Follow us on Twitter, Instagram and Linkedin
